title: Synthesis and NMR structure of p41icf, a potent inhibitor of human cathepsin L.
abstract: The total synthesis and structural characterization of the MHCII-associated p41 invariant chain fragment (P41icf) is described. P41icf plays a crucial role in the maturation of MHC class II molecules and antigen processing, acting as a highly selective cathepsin L inhibitor. P41icf synthesis was achieved using a combined solid-phase/solution approach. The entire molecule (65 residues, 7246 Da unprotected) was assembled in solution from fully protected peptides in the size range of 10 residues. After deprotection, oxidative folding in carefully adjusted experimental conditions led to the completely folded and functional P41icf with a disulfide pairing identical to that of native P41icf. CD, NMR, and surface plasmon resonance (SPR) were used for the structural and functional characterization of synthetic P41icf. CD thermal denaturation showed clear cooperative behavior. Tight cathepsin L binding was demonstrated by SPR. (1)H NMR spectroscopy at 800 MHz of unlabeled P41icf was used to solve the three-dimensional structure of the molecule. P41icf behaves as a well-folded protein domain with a topology very close to the crystallographic cathepsin L-bound form.
authors.affiliation: Institut de Recerca Biomèdica de Barcelona, Parc Científic de Barcelona, Spain.
authors.forename: Cristina
authors.initials: C
authors.lastname: Chiva
authors.forename: Philippe
authors.initials: P
authors.lastname: Barthe
authors.forename: Anna
authors.initials: A
authors.lastname: Codina
authors.forename: Margarida
authors.initials: M
authors.lastname: Gairí
authors.forename: Franck
authors.initials: F
authors.lastname: Molina
authors.forename: Claude
authors.initials: C
authors.lastname: Granier
authors.forename: Martine
authors.initials: M
authors.lastname: Pugnière
authors.forename: Tatsuya
authors.initials: T
authors.lastname: Inui
authors.forename: Hideki
authors.initials: H
authors.lastname: Nishio
authors.forename: Yuji
authors.initials: Y
authors.lastname: Nishiuchi
authors.forename: Terutoshi
authors.initials: T
authors.lastname: Kimura
authors.forename: Shumpei
authors.initials: S
authors.lastname: Sakakibara
authors.forename: Fernando
authors.initials: F
authors.lastname: Albericio
authors.forename: Ernest
authors.initials: E
authors.lastname: Giralt
mesh_terms: D000595:Amino Acid Sequence; D000944:Antigens, Differentiation, B-Lymphocyte / Q000737:chemistry* / Q000378:metabolism; D056668:Cathepsin L; D002403:Cathepsins / Q000037:antagonists & inhibitors* / Q000378:metabolism; D002942:Circular Dichroism; D003546:Cysteine Endopeptidases; D000949:Histocompatibility Antigens Class II / Q000737:chemistry* / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D008958:Models, Molecular; D008969:Molecular Sequence Data; D019906:Nuclear Magnetic Resonance, Biomolecular; D010446:Peptide Fragments / Q000138:chemical synthesis / Q000737:chemistry* / Q000378:metabolism; D011487:Protein Conformation; D012996:Solutions; D020349:Surface Plasmon Resonance
chemical_list: D000944:Antigens, Differentiation, B-Lymphocyte; D000949:Histocompatibility Antigens Class II; D010446:Peptide Fragments; D012996:Solutions; C045084:invariant chain; D002403:Cathepsins; D003546:Cysteine Endopeptidases; C534281:CTSL protein, human; D056668:Cathepsin L